|
Volumn 90, Issue 31, 1997, Pages 2-5
|
New treatments in adult cystic fibrosis
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
AMILORIDE;
ANTIBIOTIC AGENT;
CYTOKINE ANTIBODY;
DORNASE ALFA;
ELASTASE INHIBITOR;
GRANULOCYTE ANTIBODY;
IBUPROFEN;
IPRATROPIUM BROMIDE;
PLACEBO;
PREDNISOLONE;
SALBUTAMOL;
TOBRAMYCIN;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
AEROSOL;
ANTIBIOTIC THERAPY;
ARTICLE;
BACTERIAL COLONIZATION;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
ENZYME REPLACEMENT;
FEMALE;
HOME CARE;
HUMAN;
IMMUNE RESPONSE;
INHALATIONAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG FUNCTION;
LUNG INFECTION;
MAJOR CLINICAL STUDY;
MALE;
NEBULIZATION;
NUTRITIONAL SUPPORT;
PSEUDOMONAS AERUGINOSA;
QUALITY OF LIFE;
TREATMENT OUTCOME;
ADULT;
ANTI-BACTERIAL AGENTS;
CYSTIC FIBROSIS;
FORCED EXPIRATORY VOLUME;
HUMANS;
OPPORTUNISTIC INFECTIONS;
PANCREATIC ELASTASE;
|
EID: 0030985034
PISSN: 02675331
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (3)
|